Alcoholic liver disease: clinical and translational research

The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol,...

Full description

Saved in:
Bibliographic Details
Main Authors: Neuman, Manuela G. (Author) , Seitz, Helmut K. (Author) , Mueller, Sebastian (Author)
Format: Article (Journal)
Language:English
Published: 3 September 2015
In: Experimental and molecular pathology
Year: 2015, Volume: 99, Issue: 3, Pages: 596-610
ISSN:1096-0945
DOI:10.1016/j.yexmp.2015.09.001
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.yexmp.2015.09.001
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0014480015001859
Get full text
Author Notes:Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum K. Kharbanda, Natalia A. Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McKillop, Abraham Bautista, Ramon Bataller, Samuel W. French
Description
Summary:The present review spans a broad spectrum of topics dealing with alcoholic liver disease (ALD), including clinical research, translational research, pathogenesis and therapies. A special accent is placed on alcohol misuse, as alcohol is a legally commercialized and taxable product. Drinking alcohol, particularly from a young age, is a major health problem. Alcoholism is known to contribute to morbidity and mortality. A systematic literature search was performed in order to obtain updated data (2008-2015). The review is focused on genetic polymorphisms of alcohol metabolizing enzymes and the role of cytochrome p450 2E1 and iron in ALD. Alcohol-mediated hepatocarcinogenesis is also discussed in the presence or absence of co-morbidities such as viral hepatitis C as well as therapeutic the role of innate immunity in ALD-HCV. Moreover, emphasis was placed on alcohol and drug interactions, as well as liver transplantation for end-stage ALD. Finally, the time came to eradicate alcohol-induced liver and intestinal damage by using betaine.
Item Description:Gesehen am 17.08.2020
Physical Description:Online Resource
ISSN:1096-0945
DOI:10.1016/j.yexmp.2015.09.001